Navigation Links
Leading Immunologists Convene in Boston
Date:6/2/2008

Annual meeting of the Federation of Clinical Immunology Societies opens June 5

BOSTON, June 2 /PRNewswire-USNewswire/ -- Over a thousand scientists and clinicians will convene to present new advances in understanding and treating immune-mediated diseases at FOCIS 2008, the 8th annual meeting of the Federation of Clinical Immunology Societies (FOCIS), June 5-9 at the Boston Marriott Copley Place.

Conference participants will present new research findings for conditions in which the human immune system plays a significant role, such as Multiple Sclerosis, cancer, allergy and asthma, diabetes, inflammatory bowel disease, and AIDS. The topics and speakers will address underlying immune pathogenesis, novel therapies and shared insights on topics such as new mechanisms and therapeutic targets, innovations in genetic approaches and how inflammatory regulators communicate danger.

In contrast to traditional medical meetings which focus on particular medical specialties, the FOCIS approach is to highlight and probe the underlying common elements of diseases which can lead to better therapies. "As the immunology field rapidly advances in clinical trials and the introduction of new and specific immunotherapies the opportunity to share knowledge and speed progress has never been greater," says Dr. Jerry Nepom, MD, PhD, Director of the Benaroya Research Institute at Virginia Mason, Seattle, Wash. and president of FOCIS.

"Today, immunology represents a critical pathway to unlock answers to treat many of today's diseases. To that end, it is important to broaden the access to educational programs to further immunological knowledge for investigators, basic scientists and clinicians. The FOCIS annual meeting provides a forum for this timely exchange. This meeting brings special value by translating knowledge from basic science into multiple clinical disciplines to both understand and treat immune-based diseases," Nepom said.

Nepom says the translational approach to medicine is taking hold at medical schools and hospitals around the country. For instance, the National Institutes of Health, the US government's medical research body, launched its Roadmap for Medical Research to establish a call for scientists to move beyond the confines of their own discipline and explore new organizational models for team science.

"Translational medicine is the future, as we know it," Nepom said. "FOCIS has been the voice of translational immunology and we're very excited that this idea beginning to change the way we view medicine."

For more information about FOCIS 2008 and program scheduling, visit HYPERLINK "http://www.focisnet.org/" http://www.focisnet.org.


'/>"/>
SOURCE Federation of Clinical Immunology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. XIENCE(TM) V Drug Eluting Stent from Abbott Outperforms Market-Leading Stent in Reducing Major Adverse Cardiac Events at Two Years
2. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
3. Most Back Pain Could Be Cured Without Surgery or Drugs if Doctors Treated Muscles - Not the Spine - Says Leading Pain Specialist
4. Clinical Experience With Peregrines Anti-Cancer Agent Bavituximab Presented at Leading Symposium on Anti-Angiogenic Agents
5. Leading AIDS Groups Turn Up The Heat on 08 Presidential Candidates
6. Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection
7. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
8. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
9. Influenza is Leading Cause of Vaccine-Preventable Deaths for Kids; Despite CDC Recommendations, Moms Still Dont Vaccinate
10. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
11. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... January 24, 2017 www.Financialbuzz.com ... industries in the United States as ... 2016. In addition, Proposition 64, the California Cannabis Legalization Initiative, ... against on November 8, 2016. This outcome means that individuals ... and to grow a certain amount of cannabis for personal ...
(Date:1/24/2017)... , Jan. 24, 2017   QR Pharma ... company developing novel therapies for the treatment of ... the appointment of four world-class key opinion leaders ... appointments join QR Pharma,s previous roster of impressive ... direction to support the development of the breakthrough ...
(Date:1/24/2017)... 2017 Mezzion has filed a suit for ... alleging that Dr. Reddy,s committed fraud relating to Dr. ... Administration (FDA) cGMP practices, and misrepresenting its compliance to ... to Mezzion that it was compliant with FDA regulations, ... suit also states that Dr. Reddy,s misconduct was the ...
Breaking Medicine Technology:
(Date:1/24/2017)... CA (PRWEB) , ... January 24, 2017 , ... Learn ... studies, work, athletics or even in relationships. Course offered by Dr. Carol Francis ... necessary due to limited seating and the many hands-on experiences. , Dr. ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... advocacy company, announced today that its annual Solutions Series of webinars will start ... industry thought leaders discussing a number of current health and benefits topics, including ...
(Date:1/24/2017)... (PRWEB) , ... January 24, 2017 , ... Bellus Medical, ... company’s team of medical experts. In his new role Dr. Dobke will provide physician ... , Dr. Dobke is the Head of Plastic Surgery and Associate Professor of Surgery ...
(Date:1/24/2017)... ... January 24, 2017 , ... Providing solutions ... new report from the Frank Hawkins Kenan Institute of Private Enterprise ... academics and policy makers identified concrete solutions at the “What’s Next, America?” conference ...
(Date:1/24/2017)... , ... January 24, 2017 , ... The results from ... for everyone and particularly good news for prostate cancer patients: incidents of cancer is ... According to the report the cancer death rate has dropped from its peak of ...
Breaking Medicine News(10 mins):